EMC Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

EMC Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-20,922	Closed	-$762K	–	357
2021 Q4	$762K	Buy	+20,922	New	+$734K	0.41%	61
2021 Q3	–	Sell	-7,075	Closed	-$95K	–	135
2021 Q2	$95K	Sell	7,075 -1,035	-13%	-$25.5K	0.05%	105
2021 Q1	$416K	Sell	8,110 -812	-9%	-$48.9K	0.3%	78
2020 Q4	$552K	Buy	+8,922	New	+$511K	0.42%	71

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

EMC Capital Management's CCXI Position: Q1 2022 in Review

EMC Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q1 2022, closing a stake of 20,922 shares — an estimated $762K sold.

EMC Capital Management first reported a position in CCXI in Q4 2020 and held it in 4 quarters. The position peaked at $762K in Q4 2021. 176 funds tracked by Wall St. Rank hold CCXI as of Q1 2022.

EMC Capital Management reported no remaining ChemoCentryx, Inc. position as of Q1 2022 after selling out during the quarter.
EMC Capital Management sold 20,922 ChemoCentryx, Inc. shares in Q1 2022, an estimated $762K.
EMC Capital Management first reported a position in ChemoCentryx, Inc. in Q4 2020 and held it in 4 quarters.
EMC Capital Management's ChemoCentryx, Inc. position peaked at $762K in Q4 2021.
176 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2022.

Based on EMC Capital Management's 13F filing for Q1 2022, filed 16 May 2022.